Cargando…
Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery
SIMPLE SUMMARY: Nano-drug delivery systems serve as Trojan horses to carry therapeutic drugs as cargos and deliver them to target cells. The specificity of these delivery vehicles to a particular cell type can be improved if the surface of the vehicles is chemically modified in such a manner that th...
Autores principales: | Kou, Longfa, Yao, Qing, Zhang, Hailin, Chu, Maoping, Bhutia, Yangzom D., Chen, Ruijie, Ganapathy, Vadivel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599460/ https://www.ncbi.nlm.nih.gov/pubmed/33019627 http://dx.doi.org/10.3390/cancers12102837 |
Ejemplares similares
-
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
por: Kou, Longfa, et al.
Publicado: (2018) -
OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential
impact of the polyethylene glycol linker size on drug delivery in vitro,
in situ, and in vivo
por: Kou, Longfa, et al.
Publicado: (2020) -
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
por: Bhutia, Yangzom D., et al.
Publicado: (2016) -
Plasma Membrane Na(+)-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy
por: Bhutia, Yangzom D., et al.
Publicado: (2017) -
Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
por: Bhutia, Yangzom D., et al.
Publicado: (2022)